Literature DB >> 2823955

Treatment of post-kala-azar dermal leishmaniasis with sodium stibogluconate.

C P Thakur1, K Kumar, P K Sinha, B N Mishra, A K Pandey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2823955      PMCID： PMC1247932          DOI： 10.1136/bmj.295.6603.886-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  2 in total

1.  Renal clearance of pentavalent antimony (sodium stibogluconate).

Authors:  P H Rees; M I Keating; P A Kager; W T Hockmeyer
Journal:  Lancet       Date:  1980-08-02       Impact factor: 79.321

2.  Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis).

Authors:  C P Thakur
Journal:  Trans R Soc Trop Med Hyg       Date:  1984       Impact factor: 2.184
  2 in total
  4 in total

1.  Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis.

Authors:  Shyam Sundar; Anup Singh; Anurag Tiwari; Saurabh Shukla; Jaya Chakravarty; Madhukar Rai
Journal:  ISRN Parasitol       Date:  2014-03-06

2.  Therapeutic Modalities in Post Kala-azar Dermal Leishmaniasis: A Systematic Review of the Effectiveness and Safety of the Treatment Options.

Authors:  Adrija Datta; Indrashis Podder; Anupam Das; Amrita Sil; Nilay Kanti Das
Journal:  Indian J Dermatol       Date:  2021 Jan-Feb       Impact factor: 1.494

Review 3.  Complexities of assessing the disease burden attributable to leishmaniasis.

Authors:  Caryn Bern; James H Maguire; Jorge Alvar
Journal:  PLoS Negl Trop Dis       Date:  2008-10-29

Review 4.  Strategies to overcome antileishmanial drugs unresponsiveness.

Authors:  Shyam Sundar; Anup Singh; Om Prakash Singh
Journal:  J Trop Med       Date:  2014-04-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.